methyl 2-[7,12-dimethyl-2,5-di (methylcarbonyloxy)-18-oxo-(2S,4R,5R,12R,14R)-11,19,20-trioxapentacyclo[12.3.2.16,9.01,15.010,12]icosa-6,8,16-trien-4-yl]acrylate (Bipinnatin-I)

ID: ALA298966

Chembl Id: CHEMBL298966

PubChem CID: 44296307

Max Phase: Preclinical

Molecular Formula: C25H28O10

Molecular Weight: 488.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Bipinnatin-I | Bipinnatin-I|CHEMBL298966

Canonical SMILES:  C=C(C(=O)OC)[C@H]1C[C@H](OC(C)=O)C2=C[C@@H](C[C@]3(C)O[C@H]3c3cc(C)c(o3)[C@@H]1OC(C)=O)OC2=O

Standard InChI:  InChI=1S/C25H28O10/c1-11-7-19-22-25(5,35-22)10-15-8-17(24(29)33-15)18(31-13(3)26)9-16(12(2)23(28)30-6)21(20(11)34-19)32-14(4)27/h7-8,15-16,18,21-22H,2,9-10H2,1,3-6H3/t15-,16+,18-,21+,22-,25-/m0/s1

Standard InChI Key:  DORQEQXBYZYXMV-PNCPNADGSA-N

Alternative Forms

  1. Parent:

    ALA298966

    Bipinnatin-I

Associated Targets(non-human)

CHRNA1 Acetylcholine receptor (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.49Molecular Weight (Monoisotopic): 488.1682AlogP: 2.94#Rotatable Bonds: 4
Polar Surface Area: 130.87Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 12.84CX Basic pKa: CX LogP: 2.13CX LogD: 2.13
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.27Np Likeness Score: 2.77

References

1. Abramson SN, Trischman JA, Tapiolas DM, Harold EE, Fenical W, Taylor P..  (1991)  Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists.,  34  (6): [PMID:1676426] [10.1021/jm00110a007]

Source